Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for giggle incontinence in children
IRCT20111024007892N7Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methylphenidate in Giggle Incontinence (GI) and urinary incontinence (UI) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Rate of control and improvement of incontinence after use of Ritalin and Medical response category. Started Nov 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
Giggle Incontinence (GI)urinary incontinence (UI)
Beyond the preview
Go deeper on IRCT20111024007892N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111024007892N7.